JPMorgan Chase & Co’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4
| Closed | -$9 | – | 6294 |
|
|
2025
Q1 | $9 | Hold |
4
| – | – | ﹤0.01% | 6313 |
|
|
2024
Q4 | $17 | Buy |
4
+3
| +300% | +$13 | ﹤0.01% | 6229 |
|
|
2024
Q3 | $15 | Hold |
1
| – | – | ﹤0.01% | 6199 |
|
|
2024
Q2 | $25 | Hold |
1
| – | – | ﹤0.01% | 6119 |
|
|
2024
Q1 | $33 | Hold |
1
| – | – | ﹤0.01% | 6086 |
|
|
2023
Q4 | $25 | Hold |
1
| – | – | ﹤0.01% | 6267 |
|
|
2023
Q3 | $32 | Hold |
1
| – | – | ﹤0.01% | 6117 |
|
|
2023
Q2 | $31 | Hold |
1
| – | – | ﹤0.01% | 5859 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5879 |
|
|
2022
Q4 | $0 | Sell |
1
-284
| -100% | – | ﹤0.01% | 5662 |
|
|
2022
Q3 | $21K | Sell |
285
-2,394
| -89% | -$176K | ﹤0.01% | 4910 |
|
|
2022
Q2 | $416K | Sell |
2,679
-62
| -2% | -$9.63K | ﹤0.01% | 3978 |
|
|
2022
Q1 | $1.69M | Buy |
2,741
+732
| +36% | +$450K | ﹤0.01% | 3291 |
|
|
2021
Q4 | $2.51M | Buy |
2,009
+1,940
| +2,812% | +$2.43M | ﹤0.01% | 3079 |
|
|
2021
Q3 | $193K | Sell |
69
-56
| -45% | -$157K | ﹤0.01% | 4427 |
|
|
2021
Q2 | $676K | Buy |
+125
| New | +$676K | ﹤0.01% | 3836 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4874 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4871 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$3K | – | 4128 |
|
|
2016
Q2 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 4027 |
|